Aeva Technologies' Real Turning Has Arrived, And It Could Change Everything

Seeking Alpha - Thu, 11/06/2025 - 07:20

BWX Technologies prices $1.1B convertible notes offering

Seeking Alpha - Thu, 11/06/2025 - 07:20

Viatris raises outlook as emerging markets drive Q3 beat

Seeking Alpha - Thu, 11/06/2025 - 07:19

Ericsson: The Undervalued Backbone Of Global Connectivity

Seeking Alpha - Thu, 11/06/2025 - 07:17

Enovix outlines $9.5M–$10.5M Q4 revenue target while scaling AI-1 battery platform

Seeking Alpha - Thu, 11/06/2025 - 07:16

Killam Apartment REIT: Upgrading To 'Strong Buy' On Earnings Increase Anticipation

Seeking Alpha - Thu, 11/06/2025 - 07:15

Papa John's delivers tepid quarter, lowers North American sales outlook

Seeking Alpha - Thu, 11/06/2025 - 07:14

Under Armour appoints Reza Taleghani as CFO

Seeking Alpha - Thu, 11/06/2025 - 07:13

Aemetis GAAP EPS of -$0.37 misses by $0.17, revenue of $59.19M misses by $28.6M

Seeking Alpha - Thu, 11/06/2025 - 07:10

Hopes for a swift shutdown deal fade despite looming Thanksgiving travel fears

Seeking Alpha - Thu, 11/06/2025 - 07:10

Pound Sterling Declines After BoE's Dovish Hold

TalkMarkets - Thu, 11/06/2025 - 07:10
The Pound Sterling declines as four BoE MPC members voted to reduce interest rates against the three expected.

Artisan Global Opportunities Fund Q3 2025 Portfolio Update

Seeking Alpha - Thu, 11/06/2025 - 07:10

Cybeats Technologies announces C$1.4M non-brokered private placement

Seeking Alpha - Thu, 11/06/2025 - 07:09

Novavax GAAP EPS of -$1.25 misses by $0.33, revenue of $70.45M beats by $25.58M

Seeking Alpha - Thu, 11/06/2025 - 07:08

Klaviyo outlines 21–22% revenue growth target for 2026 amid rapid AI product adoption and international momentum

Seeking Alpha - Thu, 11/06/2025 - 07:07

Ralph Lauren beats top-line and bottom-line estimates; initiates Q3 and updates FY outlook

Seeking Alpha - Thu, 11/06/2025 - 07:07

4D Molecular Therapeutics stock rises after pricing $100M offering

Seeking Alpha - Thu, 11/06/2025 - 07:06

Sangamo Therapeutics GAAP EPS of -$0.11 misses by $0.11, revenue of $0.6M misses by $33.8M

Seeking Alpha - Thu, 11/06/2025 - 07:06

Fiserv Q3: Flat Revenue, Falling Earnings, And A Recovery Pushed Beyond 2026

Seeking Alpha - Thu, 11/06/2025 - 07:05

Iovance Biotherapeutics reports mixed Q3 results; reaffirms FY25 outlook

Seeking Alpha - Thu, 11/06/2025 - 07:04

Pages